Publications by authors named "Christopher K Knight"

Claim this Profile
D
Discovery, Multiparametric Optimization, and Solid-State Driven Identification of CHF-6550, a Novel Soft Dual Pharmacology Muscarinic Antagonist and β Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases.
Laura Carzaniga, Ian D Linney, Andrea Rizzi, Wolfgang Schmidt, Christopher K Knight

J Med Chem· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Clinical Candidate CHF-6366: A Novel Super-soft Dual Pharmacology Muscarinic Antagonist and β Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases.
Laura Carzaniga, Ian D Linney, Andrea Rizzi, Maurizio Delcanale, Wolfgang Schmidt, Christopher K Knight

J Med Chem· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pectenotoxin-2 synthetic studies. 3. Assessment of the capacity for stereocontrolled cyclization to form the entire C1-C26 subunit based upon the double bond geometry across C15-C16.
Patrick D O'Connor, Christopher K Knight, Dirk Friedrich, Xiaowen Peng, Leo A Paquette

J Org Chem· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis